AllDocs -> cancers

Action to Cure Kidney Cancer Awards $45,000 Grant to Fox Chase Cancer Center Researcher Action to Cure Kidney Cancer awards a $45,000 grant to Paul Cairns, Ph.D., a member of the medical science division of Fox Chase Cancer Center, to purchase a state-of-the-art DNA enhancing machine to assist his work in developing a urine screening test that will detect early stage kidney cancer . New York, NY (PRWEB) March 20, 2006 -- Action to Cure Kidney Cancer (ACKC) awards $45,000 to Paul Cairns to purchase a real-time PCR (Polymerase Chain Reaction) system that will expedite his work in the development of a urine-screening test for early stage kidney cancer as well as his research in the monitoring of treatment for the disease. This technology will enable Dr. Cairns to identify one cancer cell in 10,000 normal cells, a tenfold increase in accuracy over previous technology. Kidney ...

3rd International Kidney Cancer Symposium in Midwest Next Month Global event brings leading renal cancer investigators to Chicago. (PRWEB) October 20, 2004 -- Chicago will play host to an international group of 200 medical oncologists, urologists, and scientists at the International Kidney Cancer Symposium (IKCS), November 12, 13 and 14, 2004. The meeting is presented by the Kidney Cancer Association in joint sponsorship with the Cleveland Clinic Foundation, Taussig Cancer Center, and is the third in a series of meetings for investigators with an interest in renal cell carcinoma ( kidney cancer ). The forty faculty members for this CME-accredited event are the world’s leaders in the research, diagnosis and treatment of kidney cancer . The IKCS provides a forum for the exchange of ideas that will help to frame future research and treatment of kidney cancer . Each year, 32,000 people in the ...

Kidney Cancer Alliance Takes Action! Members Urged to Take Action Now to Increase Research Funding (PRWEB) May 24, 2004 -- Members of the Kidney Cancer Association (KCA) have joined One Voice Against Cancer (OVAC) in urging Congress to take action to cure kidney cancer and other deadly diseases by significantly increasing federal funding for programs that benefit cancer patients and their families. KCA Volunteer Governmental Affairs Committee Chair, Sarah Wise, says in Fiscal Year 2005, Congress should take action to provide: • $30.25 billion for the National Institutes of Health (NIH) ($2.37 billion increase). We appreciate the Congressional and Presidential commitment to privatizing research on health matters, demonstrated by the five year commitment to double the NIH budget. While appreciative of the hard work that went into achieving last year's 3% increase at NIH, KCA is concerned that dramatic ...

Kidney Cancer survival, incidence and mortality in NSW 1994–2000 52 The Cancer Council NSW Kidney cancer • The five-year relative survival from kidney cancer in NSW between 1994 and 2000 was 58.4% • There was no area variation in the adjusted relative risk of excess death due to kidney cancer after shrinking • There were 3,665 new cases of kidney cancer in NSW in 1994 to 1998 (2,165 males and 1,500 females) and 1,472 deaths (785 males and 687 females) • There were 15 more new cases of kidney cancer than expected in males in Central Coast; there was no area variation in the excess number of new cases in females • There was no area variation in the excess number of deaths from kidney cancer in either males or females Table 24a: Five-year relative survival, relative risk of excess death due to cancer and excess cancer deaths ...

Kidney Cancer Association Announces Research Grant The Kidney Cancer Association (KCA) today announced a $25-thousand grant to fund research sponsored by the American Foundation for Urologic Disease (AFUD). (PRWEB) October 17, 2004 -- The Kidney Cancer Association (KCA) today announced a $25-thousand grant to fund research sponsored by the American Foundation for Urologic Disease (AFUD). Manager of Corporate Development Jodi Miller welcomed the gift as, “Wonderful news!” AFUD’s goal is the Prevention and cure of urologic disease through the expansion of research, education and patient advocacy. “We are pleased to make the second in a continuing series of contributions to AFUD aimed at encouraging interest in renal cancer research,” said Bill Bro, KCA Chief Executive Officer. “Our medical advisory board has endorsed the direction of funds to AFUD, because they’re leading proponents of urologic disease ...

Saturday June 10, 2006 • ACCREDITATION The University of Miami Leonard M. Miller School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. CREDIT DESIGNATION The University of Miami Leonard M. Miller School of Medicine designates this educational activity for a maximum of 8 AMA PRA Category 1 credits.™ Physicians should only claim credit commensurate with the extent of their participation in the activity. DISCLOSURE AND CONFLICT OF INTEREST RESOLUTION All conflicts of interest of any individual(s) in a position to control the content of this CME Activity will be identified and resolved prior to this educational activity being provided. Disclosure about provider and faculty relationships, or the lack thereof, will be provided to the learners. ACKNOWLEDGMENTS ...

KIDNEY CANCER UK Fourth Annual Conference and AGM Saturday 22 May 2004 Wythenshawe Hospital South Manchester University Hospitals Trust Education and Research Centre PROGRAMME 09.00 onwards Registration, refreshments and information stalls including CancerBACUP , Manchester Welfare Rights and Benefits Service, South Manchester Healthy Living Network , The Neil Cliffe Cancer Care Centre (Wythenshawe Hospital) , Macmillan Cancer Information and Support Centre (Manchester Royal Infirmary) , Beechwood Cancer Care Centre, Stockport (complementary therapies), Patient Advice and Liaison Service (PALS, Wythenshawe Hospital) – the stalls will remain open until the end of the conference 09.30 Annual General Meeting of Kidney Cancer UK Limited (Open to all paid-up members of KCUK; agenda will be sent to members in advance) ...

KIDNEY CANCER UK Fourth Annual Conference Saturday 22 May 2004 Wythenshawe Hospital South Manchester University Hospitals Trust Education and Research Centre REGISTRATION FORM To: Kidney Cancer UK Please register the person(s) named below for the Fourth Annual KCUK Conference on 22 May. I enclose a cheque (made payable to KCUK) for the total amount due. Title/Name (BLOCK CAPITALS): Signed: Date: Organisation (if applicable) Address: Telephone: E-mail: Title/Name KCUK Member? Lunch Required? Amount Due*** (see details below) 1 YES/NO YES/NO £ 2 YES/NO YES/NO £ 3 YES/NO YES/NO £ 4 YES/NO YES/NO £ CHEQUE ENCLOSED FOR TOTAL AMOUNT: £ Please indicate which of the three afternoon workshops ...

A214: Kidney and ureter cancer tissues For research use only (formalin fixed) Specifications: • No. of cases: 31 • Tissue type: Kidney and ureter cancer tissues ( kidney :28, ureter:3) • No. of spots: 2 spots from each cancer case (62 spots) 6 non-neoplastic spots (6 spots) • Total spots: 68 • Corresponding normal tissues with cancers: Yes • Diameter: 1. 0 mm Documents : • Product specification: layout, summary of tissue spots • H&E stained images • Detailed pathological information Layout: Page 2 A214: Kidney and ureter cancer tissues For research use only (formalin fixed) Summary of tissue spots No. Sex Age Key Word Grade TNM Stage 1 1,2 M 45 RCC.conventional type 1 T1aN0M0 (I) 2 3,4 ...

TISSUE BIOMARKERS IN CANCER OF THE URINARY BLADDER AND KIDNEY High-throughput tissue microarrays in the study of urinary tract malignancies Harri Visapää Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA, and Department of Clinical Chemistry, University of Helsinki, Helsinki, Finland. Academic Dissertation To be publicly discussed with permission of the Medical Faculty of the University of Helsinki, in auditorium 3 of the Biomedicum Helsinki, Haartmaninkatu 8, on June 7th, 2003, at 12 noon. Helsinki 2003 Page 2 Supervised by Professor Aarno Palotie David Geffen School of Medicine at UCLA, Los Angeles, California, USA, and Finnish Genome Center, University of Helsinki, Helsinki, Finland Reviewed by Docent Martti Ala-Opas ...

NYS NYC 05 Staten Isl 04 Queens 03 Brooklyn 02 Bronx 01 Manhattan 62 Yates * 61 Wyoming * 60 Westchester 59 Wayne 58 Washington * 57 Warren * 56 Ulster 55 Tompkins * 54 Tioga * 53 Sullivan 52 Suffolk 51 Steuben 50 Seneca * 49 Schuyler * 48 Schoharie * 47 Schenectady 46 Saratoga 45 St Lawrence 44 Rockland 43 Rensselaer 42 Putnam * 41 Otsego * 40 Oswego 39 Orleans * 38 Orange 37 Ontario 36 Onondaga 35 Oneida 34 Niagara 33 Nassau 32 Montgomery 31 Monroe 30 Madison * 29 Livingston * 28 Lewis * 27 Jefferson * 26 Herkimer * 25 Hamilton * 24 Greene 23 Genesee 22 Fulton * 21 Franklin * 20 Essex * 19 Erie 18 Dutchess 17 Delaware * 16 Cortland * 15 Columbia * 14 Clinton * 13 Chenango * 12 Chemung ...

CANCER OF THE KIDNEY MEDICAL APPENDIX (including renal cell carcinoma, hypernephroma, nephroblastoma, Wilms’ tumour, squamous cell carcinoma, transitional cell carcinoma, sarcoma) DEFINITION 1. Cancer is a term which embraces a large number of different diseases, the common feature of which is a malignant tumour. This is a growth (neoplasm) which is not circumscribed but which infiltrates the surrounding tissues and metastasises (spreads to other sites in the body), thereby producing secondary deposits. Any tissue in the body may be affected. 2. Cancers are classified according to the tissue of origin. Carcinoma arises from epithelial tissue and sarcoma from connective tissue. The suffix blastoma implies a tumour of embryonic origin. 3. There are three main types of cancer of the kidney : 3.1. Nephroblastoma (Wilms’ tumour) is a rare tumour, occurring in childhood. ...

• CASE REPORT • Complex pattern of colon cancer recurrence including a kidney metastasis: A case report Helfried Waleczek, Moritz N Wente, Jürgen Kozianka ELSEVIER PO Box 2345, Beijing 100023, China World J Gastroenterol 2005;11(35):5571-5572 www.wjgnet.com World Journal of Gastroenterology ISSN 1007-9327 wjg@wjgnet.com © 2005 The WJG Press and Elsevier Inc. All rights reserved. Helfried Waleczek, Department of Surgery, Evangelic Hospital, Bredenscheider Straße 54, D-45525 Hattingen, Germany Moritz N Wente, Department of General Surgery, University of Heidelberg, Im Neuenheimer Feld 110, D-69120 Heidelberg, Germany Jürgen Kozianka, Department of Surgery, St-Anna-Hospital, Hospitalstraße 19, D-44649 Herne, Germany. waleczek@krankenhaus-hattingen.de Telephone: +49-2324-502-216 Fax: +49-2324-502-385 Received: 2004-04-15 Accepted: ...

NYS NYC 05 Staten Isl 04 Queens 03 Brooklyn 02 Bronx 01 Manhattan 62 Yates * 61 Wyoming * 60 Westchester 59 Wayne 58 Washington 57 Warren * 56 Ulster 55 Tompkins 54 Tioga * 53 Sullivan 52 Suffolk 51 Steuben 50 Seneca * 49 Schuyler * 48 Schoharie * 47 Schenectady 46 Saratoga 45 St Lawrence 44 Rockland 43 Rensselaer 42 Putnam 41 Otsego 40 Oswego 39 Orleans * 38 Orange 37 Ontario 36 Onondaga 35 Oneida 34 Niagara 33 Nassau 32 Montgomery 31 Monroe 30 Madison 29 Livingston 28 Lewis * 27 Jefferson 26 Herkimer * 25 Hamilton * 24 Greene 23 Genesee * 22 Fulton 21 Franklin * 20 Essex * 19 Erie 18 Dutchess 17 Delaware * 16 Cortland * 15 Columbia 14 Clinton 13 Chenango * 12 Chemung 11 Chautauqua ...

All-Ireland cancer statistics 1994-96 88 Kidney , except renal pelvis 19. MALIGNANT CANCER OF THE KIDNEY , EXCEPT RENAL PELVIS (summary) ICD-O.2 C64 ICD-10 C64 ICD-9 189.0 Figures presented here relate to kidney only, but comparison with EU figures is based on kidney in combination with renal pelvis (ICD-10 C65), ureter (C66), and urethra, paraurethral gland and unspecified urinary organs (C68). Key facts • Average of 341 new cases per year, 1994-96: 135 in females, 206 in males. • Average of 181 deaths per year: 68 in females, 113 in males. • Age-standardised incidence and mortality rates about twice as high in males as in females • 10th most common site for cancer incidence in males, 16th in females. • 10th most common cause of cancer deaths in males, 13th in females. • All-Ireland incidence rates (for kidney ...

(formalin fixed) A214: Kidney and ureter cancer tissues For research use only Specifications: • No. of cases: 31 • Tissue type: Kidney and ureter cancer tissues ( kidney :28, ureter:3) • No. of spots: 2 spots from each cancer case (62 spots) 6 non-neoplastic spots (6 spots) • Total spots: 68 • Corresponding normal tissues with cancers: Yes • Diameter: 1. 0 mm Documents : • Product specification: layout, summary of tissue spots • H&E stained images • Detailed pathological information Layout: Page 2 Summary of tissue spots (formalin fixed) A214: Kidney and ureter cancer tissues For research use only No. Sex Age KeyWord Grade TNM Stage 1 1,2 M 45 RCC.conventional type 1 T1aN0M0 (I) 2 3,4 ...

1672 Main St. Ste. E #264 • Ramona, CA 92065 • Tel: 760.789.8928 • Fax: 760.789.8929 • Toll Free: 800.475.1955 • www.proteinbiotechnologies.com HUMAN KIDNEY CANCER TISSUE ARRAY Catalog Number: TMA-130 Each three (3) dots from three different tissue spots represents one single specimen that was selected and pathologically confirmed (Normal kidney tissue array) Cases: 21 Cores: 54 Diameter: 1.5mm Thickness: 5 µm Standard IHC: CK confirmed Layout : 6 x 9 1 2 3 4 5 6 7 8 9 A 1 2 3 4 5 6 7 8 9 B 10 11 12 13 14 15 16 17 18 C 19 20 21 22 23 24 25 26 27 D 28 29 30 31 32 33 34 35 36 ...

1672 Main St. Ste. E #264 • Ramona, CA 92065 • Tel: 760.789.8928 • Fax: 760.789.8929 • Toll Free: 800.475.1955 • www.proteinbiotechnologies.com HUMAN KIDNEY CANCER TISSUE ARRAY Catalog Number: TMA-128 Each three (3) dots from three different tissue spots represents one single specimen that was selected and pathologically confirmed ( Kidney carcinoma tissue array) Cases: 23 Cores: 63 Diameter: 1.5mm Thickness: 5 µm Standard IHC: CK confirmed Layout : 7 x 9 1 2 3 4 5 6 7 8 9 A 1 2 3 4 5 6 7 8 9 B 10 11 12 13 14 15 16 17 18 C 19 20 21 22 23 24 25 26 27 D 28 29 30 31 32 33 34 35 36 ...

1672 Main St. Ste. E #264 • Ramona, CA 92065 • Tel: 760.789.8928 • Fax: 760.789.8929 • Toll Free: 800.475.1955 • www.proteinbiotechnologies.com HUMAN KIDNEY CANCER TISSUE ARRAY Catalog Number: TMA-131 Each dot represents a NORMAL tissue spot from one individual specimen that was selected and pathologically confirmed (Normal kidney tissue array) Cases: 70 Cores: 72 Diameter: 1.5mm Thickness: 5 µm Standard IHC: Villin confirmed Layout : 8 x 9 1 2 3 4 5 6 7 8 9 A 1 2 3 4 5 6 7 8 9 B 10 11 12 13 14 15 16 17 18 C 19 20 21 22 23 24 25 26 27 D 28 29 30 31 32 33 34 35 36 E ...

1672 Main St. Ste. E #264 • Ramona, CA 92065 • Tel: 760.789.8928 • Fax: 760.789.8929 • Toll Free: 800.475.1955 • www.proteinbiotechnologies.com HUMAN KIDNEY CANCER TISSUE ARRAY Catalog Number: TMA-129 Each dot represents a DISEASED tissue spot from one individual specimen that was selected and pathologically confirmed ( Kidney carcinoma tissue array) Cases: 71 Cores: 72 Diameter: 1.5mm Thickness: 5 µm Standard IHC: CK confirmed Layout : 8 x 9 1 2 3 4 5 6 7 8 9 A 1 2 3 4 5 6 7 8 9 B 10 11 12 13 14 15 16 17 18 C 19 20 21 22 23 24 25 26 27 D 28 29 30 31 32 33 34 35 36 E ...

Cancer Mortality by Socioeconomic Status in Queensland Cancer of Kidney And Other Renal Tract 0 3 6 9 12 15 0 3 6 9 12 15 Male Female Rate per 100,000 population Rate per 100,000 population Avg No. Avg No. per Year per Year Mortality of Cancer of Kidney And Other Renal Tract, by SEIFA category and Sex, Queensland, Five Year Average, 1998 to 2002 6.4 12 3.2 8 High SES SEIFA Quintile 5.7 17 3.2 11 Mod. high SES 5.5 17 3.8 13 Moderate SES 6.5 26 4.0 20 Mod. Low SES 6.1 19 4.2 16 Low SES Note: Rates are age standardised to the Australian population as at 30 June 2001. ...

Cancer Mortality by Proportion Indigenous Population in Queensland Cancer of Kidney And Other Renal Tract 0 3 6 9 12 15 0 3 6 9 12 15 Male Female Rate per 100,000 population Rate per 100,000 population Avg No. Avg No. per Year per Year Mortality of Cancer of Kidney And Other Renal Tract, by Indigenous Proportion and Sex, Queensland, Five Year Average, 1998 to 2002 6.2 84 3.7 62 <5% Indigenous Proportion Indigenous Population 5.1 7 4.5 6 At least 5% Indigenous Note: Rates are age standardised to the Australian population as at 30 June 2001. Numbers and rates are averaged over five years, and based on place of usual residence at time of diagnosis. The range shown by the orange line ...

Kidney cancer The kidneys are part of the urinary system. The human body has two kidneys, one on either side of the middle of the back, just under the ribs. The kidneys: • Remove waste products from the blood. • Produce hormones that regulate blood pressure, control the body's calcium levels, and trigger the production of red blood cells in bones. Around 85 per cent of kidney cancers are renal cell carcinomas. Cancer cells initially grow in the lining of one or both kidneys. Without treatment, the cancer may spread to other areas of the body. Kidney cancer is more common in people over the age of 55 years. It is more common in men than women. About 500 Victorians are diagnosed with kidney cancer every year. Symptoms In its early stages, kidney cancer may have no symptoms. The disease may be discovered by accident, when the ...

kidney cancer 1581 Kidney Cancer Incidence: 36,000 cases/year in U.S. 12,700 deaths/year in U.S. 3% of all cancers Symptoms: blood in urine, flank pain, fatigue, symptoms from metastases 30 % of patients have distant metastases at diagnosis No screening tests available Diagnosis by CT scan-- accuracy 98% if symptomatic Cause--more common in men and in smokers, hypertension, overweight,?organic solvents California Kidney Cancer Foundation FOUNDED 1994 TO MAKE NEW AND ADVANCED FORMS OF THERAPY FOR KIDNEY CANCER AVAILABLE THROUGHOUT NORTHERN CALIFORNIA MULTIDISCIPLINARY APPROACH TO PATIENT CARE WITH CLINICAL RESEARCH USING IMMUNOTHERAPY WITH TARGETED THERAPY Kidney Cancer Staging and 5-year Survival Stage 1 Tumor < 7cm size Stage 2 ...